Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | PBRM1 | Q86U86 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | NSD2 | O96028 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.35 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.35 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.34 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 2/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29606274 | 1.00 | CYP3A4 (0.50) | CYP3A4ALDH1A1KDM4ELMNASMN1; SMN2 | |
| SCHEMBL9957687 | 0.83 | CYP3A4 (0.48) | CYP3A4ALDH1A1KDM4ELMNASMN1; SMN2 | |
| SCHEMBL30945800 | 0.83 | CYP3A4 (0.48) | CYP3A4ALDH1A1KDM4ELMNASMN1; SMN2 | |
| SCHEMBL14033994 | 0.82 | ALDH1A1 (0.45) | CYP3A4ALDH1A1KDM4ELMNASMN1; SMN2 | |
| SCHEMBL9051530 | 0.82 | CYP3A4 (0.48) | CYP3A4ALDH1A1KDM4ETRPA1KMT2A | |
| SCHEMBL4687669 | 0.82 | ALDH1A1 (0.52) | CYP3A4ALDH1A1KDM4ESMN1; SMN2KMT2A | |
| SCHEMBL922165 | 0.81 | TSHR (0.53) | CYP3A4ALDH1A1KDM4ELMNASMN1; SMN2 | |
| SCHEMBL2137249 | 0.80 | ALDH1A1 (0.45) | CYP3A4ALDH1A1KDM4ELMNASMN1; SMN2 | |
| SCHEMBL7429738 | 0.80 | ALDH1A1 (0.51) | CYP3A4ALDH1A1KDM4ELMNASMN1; SMN2 | |
| Methane SCHEMBL5177350 | 0.80 | ALDH1A1 (0.50) | CYP3A4ALDH1A1KDM4ESMN1; SMN2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120012796-A1 | CONDUCTIVE FILMS BASED ON GRAPHENE AND PROCESS FOR PREPARING THE SAME | NANKAI UNIVERSITY (CN) | 2012-01-19 | — | — | US | claimed |
| US-20230416448-A1 | THERMOSETTING EPOXY RESIN COMPOSITION, MOLDED ARTICLE OF SAME, FIBER-REINFORCED COMPOSITE MATERIAL, MOLDING MATERIAL FOR FIBER-REINFORCED COMPOSITE MATERIALS, AND METHOD FOR PRODUCING FIBER-REINFORCED COMPOSITE MATERIAL | TORAY INDUSTRIES, INC. (JP) | 2023-12-28 | — | — | US | disclosed |
| US-20230416521-A1 | THERMOSETTING EPOXY RESIN COMPOSITION, MOLDED ARTICLE FROM THERMOSETTING EPOXY RESIN, MOLDING MATERIAL FOR FIBER-REINFORCED COMPOSITE MATERIAL, FIBER-REINFORCED COMPOSITE MATERIAL, AND METHOD FOR PRODUCING FIBER-REINFORCED COMPOSITE MATERIAL | TORAY INDUSTRIES, INC. (JP) | 2023-12-28 | — | — | US | disclosed |
| US-20230406994-A1 | THERMOSETTING EPOXY RESIN COMPOSITION, MOLDED ARTICLE OF SAME, FIBER-REINFORCED COMPOSITE MATERIAL, MOLDING MATERIAL FOR FIBER-REINFORCED COMPOSITE MATERIALS, AND METHOD FOR PRODUCING FIBER-REINFORCED COMPOSITE MATERIAL | TORAY INDUSTRIES, INC. (JP) | 2023-12-21 | — | — | US | disclosed |
| EP-4265664-A1 | THERMOSETTING EPOXY RESIN COMPOSITION, MOLDED ARTICLE OF SAME, FIBER-REINFORCED COMPOSITE MATERIAL, MOLDING MATERIAL FOR FIBER-REINFORCED COMPOSITE MATERIALS, AND METHOD FOR PRODUCING FIBER-REINFORCED COMPOSITE MATERIAL | Toray Industries, Inc. (JP) | 2023-10-25 | — | — | EP | disclosed |
| WO-2022124191-A1 | THERMOSETTING EPOXY RESIN COMPOSITION, MOLDED ARTICLE FROM THERMOSETTING EPOXY RESIN, MOLDING MATERIAL FOR FIBER-REINFORCED COMPOSITE MATERIAL, FIBER-REINFORCED COMPOSITE MATERIAL, AND METHOD FOR PRODUCING FIBER-REINFORCED COMPOSITE MATERIAL | 東レ株式会社 | 2022-06-16 | — | — | WO | disclosed |
| WO-2022102467-A1 | THERMOSETTING EPOXY RESIN COMPOSITION, MOLDED ARTICLE OF SAME, FIBER-REINFORCED COMPOSITE MATERIAL, MOLDING MATERIAL FOR FIBER-REINFORCED COMPOSITE MATERIALS, AND METHOD FOR PRODUCING FIBER-REINFORCED COMPOSITE MATERIAL | 東レ株式会社 | 2022-05-19 | — | — | WO | disclosed |
| EP-2190054-B1 | NONAQUEOUS ELECTROLYTE SOLUTION FOR SECONDARY BATTERY AND NONAQUEOUS ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEM CORP (JP) | 2016-10-26 | — | — | EP | disclosed |
| US-20140127590-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION FOR SECONDARY BATTERY AND NONAQUEOUS ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2014-05-08 | — | — | US | disclosed |
| EP-2121621-B1 | LXR AND FXR MODULATORS | EXELIXIS PATENT CO LLC (US) | 2014-05-07 | — | — | EP | disclosed |
| WO-2003022219-A2 | BIARYLAMINO PURINE ANTIPROLIFERATIVE AGENTS | ALBANY MOLECULAR RESEARCH, INC. (US) | 2003-03-20 | — | — | WO | disclosed |
| WO-2003022805-A2 | HETEROCYCLE SUBSTITUTED PURINES AS ANTIPROLIFERATIVE AGENTS | ALBANY MOLECULAR RESEARCH, INC. (US) | 2003-03-20 | — | — | WO | disclosed |
| WO-2003022216-A2 | BIARYL SUBSTITUTED PURINE DERIVATIVES AS POTENT ANTIPROLIFERATIVE AGENTS | ALBANY MOLECULAR RESEARCH, INC. (US) | 2003-03-20 | — | — | WO | disclosed |
| US-20020091263-A1 | Biaryl substituted purine derivatives as potent antiproliferative agents | ALBANY MOLECULAR RESEARCH, INC. | 2002-07-11 | — | — | US | disclosed |
| EP-1220836-A2 | BENZYLCYCLOALKYL AMINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | Bristol-Myers Squibb Pharma Company (US) | 2002-07-10 | — | — | EP | disclosed |
| WO-2002041871-A2 | COMPOSITION COMPRISING AN IMEXON OR DERIVATIVES THEREOF AND LIPIDS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2002-05-30 | — | — | WO | disclosed |
| EP-1165561-A1 | 6-SUBSTITUTED BIARYL PURINE DERIVATIVES AS POTENT CYCLIN/CDK INHIBITORS AND ANTIPROLIFERATIVE AGENTS | ALBANY MOLECULAR RESEARCH, INC. (US) | 2002-01-02 | — | — | EP | disclosed |
| US-6248765-B1 | ANTIINFLAMMATORY AGENTS; HYPOTENSIVE AGENTS | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICAL (FR) | 2001-06-19 | — | — | US | disclosed |
| WO-2001028987-A1 | BENZYLCYCLOALKYL AMINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | DU PONT PHARMACEUTICALS COMPANY (US) | 2001-04-26 | — | — | WO | disclosed |
| WO-2000055161-A1 | 6-SUBSTITUTED BIARYL PURINE DERIVATIVES AS POTENT CYCLIN/CDK INHIBITORS AND ANTIPROLIFERATIVE AGENTS | ALBANY MOLECULAR RESEARCH, INC. (US) | 2000-09-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020091263-A1 | Biaryl substituted purine derivatives as potent antiproliferative agents | CCNA1, CCNA2, CDK2 | CYP3A4 2492/4885ALDH1A1 1931/4885KDM4E 469/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.